Kirkbride Center

What Kirkbride Center does

Kirkbride Center is a 302-bed, CARF-accredited behavioral health care facility located on a 17-acre campus in the University City neighborhood of Philadelphia. The organization provides a full continuum of addiction treatment services organized across three ASAM-aligned tiers: medically monitored detoxification (21 beds), short- and long-term residential rehabilitation (249 beds), and outpatient linkages. Its core clinical offering is medication-assisted treatment (MAT), and the facility is distinguished by offering all three FDA-approved pharmacotherapies (methadone, buprenorphine/Suboxone, and naltrexone/Vivitrol) in both detoxification and maintenance modalities — a capability held by only an estimated 2.7% of U.S. drug and alcohol rehab centers. Treatment is delivered by a multidisciplinary team and is supported by a defined set of evidence-based modalities including Cognitive Behavioral Therapy, Trauma Recovery Empowerment Model (TREM) for trauma survivors, and adjunctive therapies (art, music, yoga, gardening, mural arts).

The business model is a B2C-with-payer-intermediary healthcare services model. The facility accepts admissions 24/7 by phone, fax, and walk-in, with the majority of volume routed through insurance contracts with Community Behavioral Health, Pennsylvania Medicaid, Magellan, Independence Blue Cross, Aetna, and the Behavioral Health Special Initiative. A self-pay and payment-plan option exists for uninsured patients. Demand is generated through referral partnerships with crisis response centers, inpatient and outpatient treatment providers, the Forensic Intensive Recovery Program, and the court system. The company is privately held, founded in its current form in 1997, and led by President/CEO Rose S. DiOttavio, who has long-tenured ties to related entity CoreCare Systems, Inc. Notable regulatory assets include the first Suboxone maintenance license granted to an inpatient program in greater Philadelphia, full 3-year CARF accreditation (effective April 2026), and SAMHSA Opioid Treatment Program certification.

Name

Kirkbride Center

Legal name

Kirkbride Center

Website

https://kirkbridecenter.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Kirkbride Center is a 302-bed, CARF-accredited behavioral health facility in Philadelphia providing medically monitored detox, residential rehabilitation, and the full range of medication-assisted treatment (methadone, buprenorphine, naltrexone) to adults with substance use and co-occurring disorders, reimbursed primarily through Medicaid and managed care.

Ownership category

akta.pro rank

Product category

Behavioral Health and Addiction Treatment Services

NAICS

Residential Mental Health and Substance Abuse Facilities (623220), Residential Mental Health and Substance Abuse Facilities (62322)

SIC

Services-Nursing & Personal Care Facilities (8050), Services-Health Services (8000)

akta.pro primary industry

Residential Substance Use Rehabilitation (Inpatient Rehab) (HLAFACAE)

akta.pro secondary industry

Peer Support, Recovery Coaching & Sober Living Services (HLAFACAN)

Keywords

• Inpatient addiction treatment
• Medication-assisted treatment
• Behavioral health services
• Residential rehabilitation
• Opioid treatment program

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Insurance Reimbursement: Treatment is covered by most insurance plans including Community Behavioral Health, Behavioral Health Special Initiative (BHSI), Independence Blue Cross, Magellan, Medical Assistance, Pennsylvania Medicaid, and Aetna. Insurance managed by Community Behavioral Health includes Aetna Better Health, Health Partners, CoventryCares, Keystone First, United HealthCare Community Plan.
2. Self-Pay/Payment Plans: For those without insurance, Kirkbride accepts Behavioral Health Special Initiative and can create personal payment plan arrangements to help clients pay for treatment without financial hardship.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Kirkbride Center provides a continuum of inpatient addiction treatment services on its 17-acre Philadelphia campus, including 21-bed medically monitored detoxification, 249-bed residential rehabilitation (short-term and long-term), and outpatient medication-assisted treatment (MAT) using methadone, buprenorphine (Suboxone), and naltrexone (Vivitrol). Treatment is integrated with evidence-based psychotherapy (individual, group, TREM trauma recovery) and adjunctive modalities such as art, music, yoga, gardening, and Smart Recovery. Services are reimbursed primarily through major insurers and Pennsylvania Medicaid.

Product overview

Kirkbride Center is a 302-bed licensed comprehensive behavioral health care facility offering a continuum of addiction treatment services. The organization provides a tiered program architecture consisting of medically monitored detoxification (21 beds), residential rehabilitation (249 beds with short-term and long-term options), and outpatient services. Medication-assisted treatment (MAT) is a core offering with all three FDA-approved agents: methadone, buprenorphine (Suboxone), and naltrexone (Vivitrol). The treatment model integrates pharmacotherapy with evidence-based psychotherapeutic interventions including individual and group therapy, trauma recovery programs (TREM), and complementary therapies (art, music, yoga, gardening, mural arts). The facility operates both general addiction programs and specialized tracks for co-occurring disorders and trauma survivors.

Differentiator

Problem solved

Functional benefit

Products and services

• Medically Monitored Detoxification Non-hospital, medically monitored detoxification service that gently weans individuals off substances causing withdrawal symptoms, minimizing discomfort and risk of complications; currently consists of 21 beds and is intended for adults facing drug or alcohol addiction.
• Residential Rehabilitation 249-bed residential rehabilitation program delivered on the Philadelphia campus, with short-term and long-term levels of care, drug-free rehabilitation, and integrated co-occurring disorders treatment; serves adults with substance use disorders.
• Methadone Maintenance Treatment Methadone-based medication-assisted treatment for opioid addiction, offered as both detoxification and maintenance to mitigate withdrawal symptoms; part of the facility's full range of pharmacotherapies since 2000.
• Suboxone (Buprenorphine) Treatment Buprenorphine (Suboxone) medication-assisted treatment for opioid addiction, including initiation of maintenance therapy; Kirkbride was the first inpatient program in greater Philadelphia area licensed by the state to initiate Suboxone maintenance, with outpatient referral agreements in Philadelphia, Delaware, and Bucks counties.
• Vivitrol (Naltrexone) Treatment Naltrexone-based medication-assisted treatment available in both oral and extended-release (Vivitrol) forms for opioid addiction, offered as both detoxification and maintenance.
• Gender-Specific Trauma Recovery (TREM) Fully manualized Trauma Recovery Empowerment Model (TREM) group intervention for trauma survivors, using cognitive restructuring, psycho-education, and coping skills training across 75-minute weekly sessions covering specific recovery topics; offered for both women and men.
• Co-Occurring Disorders Treatment Integrated treatment program that addresses both substance use disorders and co-occurring mental health conditions within the same treatment plan.
• Individual Psychotherapy One-on-one therapeutic sessions with a primary therapist that address each patient's individual needs and treatment goals.
• Group Psychotherapy Group therapy sessions covering Relapse Proneness, Rational Emotive Behavioral Therapy, Reality Therapy, Grief and Loss, Alternative Coping Skills, Understanding Codependency, Cognitive Behavioral Therapy, Mindfulness, Rational Self-Talk, Assertive Communication, Comorbidity, Healing Your Inner Child, Mapping Your Recovery, and The Twelve Steps.
• Mural Arts Program Therapeutic art programming delivered in partnership with the Philadelphia Mural Arts Program to support recovery through creative expression as part of the multidisciplinary treatment approach.
• Gardening Program Therapeutic gardening activities conducted on the 17-acre campus, supporting physical wellness and the holistic treatment approach.
• Smart Recovery Self-help recovery program integrated into the broader treatment programming at the facility.
• Specialized Trauma Survivor Program Specialized programming for people previously involved in sex work and trauma survivors, providing mutual support and trauma processing.
• Medication Management Clinical service providing ongoing medication management as part of each patient's comprehensive treatment plan.

Quantifiable outcome

• Up to 70% success rate for alcohol dependence treatment; up to 60% for cocaine treatment; up to 80% for opiate dependence treatment

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Philadelphia Mural Arts ProgramminorStrategic or Co-development Partner · 10 October 2016Kirkbride Center partnered with Philadelphia Mural Arts Program to provide therapeutic art programming for patients in recovery, supporting the healing process through creative expression.
• AMFAR (American Foundation for AIDS Research)minorStrategic or Co-development PartnerRecognized by AMFAR for work in opioid addiction treatment access. AMFAR report highlighted gaps in access to opioid addiction treatment, noting Kirkbride's services.
• Outpatient Suboxone Referral Partners (Philadelphia, Delaware, Bucks counties)coreImplementation/ SI/ Consulting PartnerEstablished outpatient programs in Philadelphia, Delaware, and Bucks counties for continuation of Suboxone maintenance after inpatient discharge, ensuring continuum of care for patients.
• Community Connections DC (TREM)minorStrategic or Co-development PartnerKirkbride offers TREM (Trauma Recovery Empowerment Model), a fully manualized trauma recovery intervention developed by Community Connections DC.

Scale indicators3 records

Recent moves7 records

Expansion highlights3 records

Direct peers

• Pyramid Healthcare: Pyramid Healthcare operates residential, detox, and outpatient addiction treatment programs across Pennsylvania, including the former White Deer Run network. Directly comparable in service lines and regional scope; now PE-backed, providing a useful private-market benchmark.
• Gaudenzia: Gaudenzia is one of the largest non-profit addiction and co-occurring disorder treatment providers in Pennsylvania, operating residential and outpatient programs in the Philadelphia region. Comparable in target population, MAT offerings, and referral-based intake model.
• Eagleville Hospital: Eagleville is a long-standing Philadelphia-area behavioral health hospital specializing in substance use disorder treatment, including detox and residential rehab. Directly competes with Kirkbride for the same Philadelphia referral pool and patient population.
• Caron Treatment Centers: Caron is a Pennsylvania-based, non-profit addiction treatment provider offering residential rehab, detox, and MAT across multiple locations. Directly comparable to Kirkbride in service mix, geographic region, and patient acuity, though larger and broader in footprint.
• Gateway Rehab: Gateway Rehab operates a network of addiction treatment centers across western Pennsylvania offering detox, residential, and outpatient services including MAT. Comparable in service model and Pennsylvania geography, with a larger multi-site footprint than Kirkbride.
• Valley Forge Medical Center & Hospital: VFMC is a for-profit hospital in southeastern Pennsylvania providing medically monitored detox, short- and long-term residential addiction treatment, and MAT. Closely comparable in scale, ownership type, and service mix to Kirkbride.

Broad incumbents

• Hazelden Betty Ford Foundation: Hazelden Betty Ford is the largest non-profit addiction treatment provider in the U.S., with residential, detox, MAT, and extended care programming nationally. Comparable in core clinical model and CARF accreditation approach; operates at significantly greater scale and brand recognition.
• Penn Medicine - Department of Psychiatry: Penn Medicine operates psychiatric and addiction medicine services at its Philadelphia academic medical center, including MAT and inpatient behavioral health. Provides referral competition and partnership potential from the same Philadelphia referral ecosystem.

Regional players

• Mercy Behavioral Health (Pittsburgh Mercy): Pittsburgh Mercy operates inpatient behavioral health and SUD programs in western Pennsylvania under a Catholic health system umbrella. Comparable in residential SUD offerings and Pennsylvania service area, though western-PA-focused rather than Philadelphia.
• Behavioral Wellness Center at Girard (Temple Health): Temple Health's behavioral health services include inpatient psychiatric and substance use treatment in Philadelphia. Operates in the same regional referral network and patient population as Kirkbride but as part of a broader academic health system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kirkbride Center